comparemela.com

Latest Breaking News On - Van lanschot kempen life sciences conference - Page 1 : comparemela.com

Sensorion : Inside Information / Other news releases -April 10, 2024 at 03:13 am EDT

Press release Sensorion Announces its Participation in the Van Lanschot Kempen s Life Sciences Conference Montpellier,.

Noord hollandInstitut pasteurVan lanschotNicolas entzVan lanschot kempen life sciences conferenceKempen life sciences conferenceVan lanschot kempenLife sciences conferenceCisplatin induced ototoxicityCochlear limitedSudden sensorineural hearing lossInvestor relations

Sensorion Announces its Participation in the Van Lanschot Kempen s Life Sciences Conference

Regulatory News: Sensorion a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the field of hearing loss.

Noord hollandInstitut pasteurVan lanschot kempen life sciences conferenceRegulatory newsVan lanschot kempenLife sciences conferenceCisplatin induced ototoxicityCochlear limitedSudden sensorineural hearing loss

ORYZON to Provide Corporate Progress Updates at Several Events in April

Investing in Oncology Forum 2024Van Lanschot Kempen Life Sciences Conference Swiss Biotech Day 2024LSX World CongressMADRID, Spain and BOSTON, Apr.

San diegoUnited statesComunidad autonoma de catalunaAshleyr robinsonPatricia cobo mario corderaUs national cancer instituteFox chase cancer centerWorld congressImpact on eu biotech pharma companiesOncology forumLifesci advisorsDevelopment agreementVan lanschot kempen life sciences conferenceBiotech dayVan lanschot kempen life sciencesSwiss biotech day

Oculis to Participate at Upcoming April Investor

ZUG, Switzerland and BOSTON, April 04, 2024 (GLOBE NEWSWIRE) Oculis Holding AG (Nasdaq: OCS) (“Oculis”), a global biopharmaceutical company.

Noord hollandUnited statesCorey davisSylvia cheungOculis holding ag nasdaqVan lanschot kempen life sciences conferenceRiad sherifChief executiveNasdaq ocsOculis holding ag

Innate Pharma : Inside Information / Other news releases

PRESS RELEASE INNATE PHARMA TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCE Marseille,. | April 21, 2023

Noord hollandTwitterand linkedinVan lanschot kempen life sciences conferenceEuronext parisLanschot kempen life sciences conferenceEngager therapeuticsInnate pharmaPrivate securities litigation reform actInnate pharma stock exchangePress releaseNvestor iph fr0010331421

vimarsana © 2020. All Rights Reserved.